3 results
Approved WMORecruiting
The primary objective of this study is:To determine the response rate [the combined complete response (CR) + partial response (PR) + minimal response (MR)] following treatment with BDR in patients with previously untreated WM.Secondary objectives…
Approved WMORecruiting
To assess the safety and tolerability of PLN 74809 in participants with PSC and suspected liver fibrosis
Approved WMORecruiting
Primary objectivesThis Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis and consists of 2 sequential periods - an initial double-blind placebo-controlled period of minimum 72 weeks followed by a double-blind…